As part of our mission to drive meaningful collaboration in liver cancer worldwide, we are proud to partner with SIO (Society of Interventional Oncology). to enhance the dialogue around locoregional therapy. The day before the ILCA Single Topic Workshop, SIO will host their own event in Chicago – the NEXT Summit – focused on exploring what’s next in combination therapy, a timely complement to our deep dive into Y90 and TACE.

If you’d like to attend both events, we’re offering a reduced fee that gives you access to a broader range of insights and the opportunity to engage with an even wider network of experts.

Participants will also enjoy a Joint Society Reception on the evening of June 5, an ideal opportunity to connect with peers and speakers in an informal setting before the workshop begins.